ProShares UltraShort Bloomberg Natural Gas ETF vs NeoGenomics Inc. Common Stock — how do they compare? ProShares UltraShort Bloomberg Natural Gas ETF trades at $24.59 (market cap $140.85M), while NeoGenomics Inc. Common Stock trades at $16.95 (market cap $2.17B). The key difference: NeoGenomics Inc. Common Stock is far larger — about 15.4× ProShares UltraShort Bloomberg Natural Gas ETF's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, ProShares UltraShort Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ProShares UltraShort Bloomberg Natural Gas ETF for 10 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| KOLD | NEO | |
|---|---|---|
Market Cap | $140.85M | $2.17B |
Volume | 6,606,542 | 1,615,943 |
Sector | Leveraged / Inverse | Health |
52-Week High | $49.39 | $19.91 |
52-Week Low | $13.58 | $7.19 |
Typical Hold Time | 10 Days | 0 Days |
Enterprise Value | — | $2.47B |
Signals from Pluang's Aura AI — not financial advice
KOLD stock trades at $24.59, up 3.1% in the past 24 hours, with technical indicators showing a bearish trend as moving averages signal strong selling pressure. The stock faces resistance at $25 and support at $24, with RSI levels suggesting potential oversold conditions. Recent energy market volatility, including record natural gas production and Middle East tensions, creates a complex backdrop for this energy-focused investment.
The outlook remains cautious given the bearish technical signals and energy market uncertainties. While oversold conditions may present short-term opportunities, sustained recovery depends on natural gas price stabilization and resolution of geopolitical tensions affecting energy markets.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →